Michael J. Fox will be returning to television screens in 2013, it was reported yesterday, after more than a decade of only sporadic guest appearances, thanks to a new drug regimen involving a combination of drugs to effectively control the tics that are characteristic of Parkinson’s disease.
In April it was announced that the Foundation Michael set up to help in the quest for a cure for Parkinson’s disease, the largest private foundation for Parkinson’s research, would partner with the French drug company Sanofi to trial an experimental treatment they had developed for Parkinson’s. The Michael J. Fox foundation sponsored a clinical trial to study the new drug, which targets cognitive dysfunction, one of the more severe symptoms that can occur in Parkinson’s disease.
In May, Fox told ABC News that a new drug regimen has helped him control the tics that are a result of the disease and allowed him to take on more acting roles.
Michael has been treating the disease with the drug Sinemet, often taking more than the prescribed amount in order to cope with the demands of his public appearances, reported The Examiner.com.
Michael will star in a comedy that’s in development at Sony Pictures Television for 2013, according to people with knowledge of the project. The project has drawn strong interest from the major networks, with many realizing the value that Michael’s return to television could bring them. He will be working with Will Gluck, director of the film ‘Easy A,’ and writer Sam Laybourne, whose credits include “Cougar Town” and ‘Arrested Development’.